Zoetis to Participate in the 41st Annual J.P. Morgan Healthcare Conference
Zoetis (NYSE: ZTS) will participate in the 41st Annual J.P. Morgan Healthcare Conference on January 9, 2023. CEO Kristin Peck is scheduled to present at 1:30 p.m. PT and answer analyst questions. Investors can access a live audio webcast of the presentation through the company's investor relations site. A replay will also be available post-event. Zoetis, a leading animal health company, generated $7.8 billion in revenue in 2021 and operates in over 100 countries, focusing on animal care and health innovations.
- None.
- None.
Investors and other interested parties will be able to access a live audio webcast of the presentation by visiting http://investor.zoetis.com/events-presentations. A replay of the presentation will also be available on the Zoetis website at the conclusion of the event.
About Zoetis
As the world’s leading animal health company, Zoetis is driven by a singular purpose: to nurture our world and humankind by advancing care for animals. After 70 years innovating ways to predict, prevent, detect, and treat animal illness, Zoetis continues to stand by those raising and caring for animals worldwide – from livestock farmers to veterinarians and pet owners. The company’s leading portfolio and pipeline of medicines, vaccines, diagnostics and technologies make a difference in over 100 countries. A Fortune 500 company, Zoetis generated revenue of
ZTS-COR
ZTS-IR
View source version on businesswire.com: https://www.businesswire.com/news/home/20221220005754/en/
Media:
1-973-443-2742 (o)
william.price@zoetis.com
1-973-443-2777 (o)
kristen.seely@zoetis.com
Investors:
1-973-822-7141 (o)
steve.frank@zoetis.com
1-973-443-2792 (o)
nick.soonthornchai@zoetis.com
Source:
FAQ
When is Zoetis presenting at the J.P. Morgan Healthcare Conference?
Who will represent Zoetis at the conference?
How can I access Zoetis' presentation at the conference?
What was Zoetis' revenue in 2021?